Skip to main content
. 2018 Oct 31;11:7625–7634. doi: 10.2147/OTT.S169531

Table 2.

Kaplan–Meier survival analyses and log-rank tests

Variables Cases (n) Survival months (Mean ± SD) 5-year OS (%) P-value
Gender 0.913
Female 23 73.80±6.72 65.5
Male 64 76.11±3.42 82.3
Age (years) 0.010a
≤58 41 84.19±3.13 96.0
>58 46 67.29±4.77 61.1
Location 0.017a
Ascending 33 64.87±4.62 62.7
Transverse 13 68.52±9.78 64.3
Descending/sigmoid 41 85.07±3.35 95.5
Differentiation <0.001a
Poor 17 67.87±5.93 77.5
Moderate 66 80.05±3.45 83.9
Well 4 42.67±2.96 0.00
Tumor size (diameter, cm) 0.920
≤5.0 56 74.85±4.05 73.3
>5.0 31 75.19±4.18 85.9
Invasion depth 0.253
T1–T2 36 81.34±3.03 90.9
T3–T4 51 72.19±4.85 68.5
Lymph node metastasis 0.011a
Negative 39 86.59±4.02 90.2
Positive 48 69.10±4.05 69.7
PYK2 expression 0.001a
Low 44 84.61±3.57 96.6
High 43 64.42±4.49 57.6

Note:

a

Statistically significant (P<0.05).